Excited to share our new publication in Immunology Letters!
This work adds new insights into the early virus-related pathogenesis of T1D and highlight potential targets for preventing virus-induced T1D.
https://t.co/9KdHE6aqWT
Our new type 1 diabetes paper showing that the expression of innate anti-viral immune pathway genes (TLR7, OAS1, OAS3 etc.) is increased in individuals with predisposing HLA risk haplotypes and high HbA1c, respectively. https://t.co/OgP3GY9pD5
Type 1 diabetes could begin with alterations in innate anti-viral immunity, which are already at this stage associated with HLA risk haplotypes.
👇
https://t.co/4KkHQE4ESj
Conferences, Collaborations, and Publication: What a Remarkable Month! 🎉
So much has happened within a short period of time, and I feel thrilled, amazed, and deeply thankful to be part of such a cutting-edge research group within the field of #Type1Diab…https://t.co/axEJJG5ftg
Huge congratulations 🎊 to Caroline Frørup for a successful PhD defense on "Role of Non-coding RNAs in Type 1 Diabetes" . It has been a pleasure being a co-supervisor along with @FPociot, Joachim Størling and Jesper Johannesen. @Stenodiabetes@T1DBiology
Exciting news from Metabolism Day 2023!
I had the pleasure of presenting a poster earlier this month at the Novo Nordisk Foundation, Center for Basic Metabolic Research event at Panum, representing the experimental research unit of the Department of Pat…https://t.co/UORjaqEYZS